<DOC>
	<DOCNO>NCT02154477</DOCNO>
	<brief_summary>Over last year , study show men type 2 diabetes sometimes develop condition call hypogonadotrophic hypogonadism ( HH ) . People condition produce little sex hormone . Obesity metabolic syndrome also associate HH . Research suggest insulin brain may benefit gland release hormone . During study , subject spray small amount insulin nose.This increase insulin concentration brain . The purpose study find effect one dose intranasal insulin release LH ( sex hormone ) obese diabetic men HH .</brief_summary>
	<brief_title>Effect Intranasal Insulin LH Concentrations Man</brief_title>
	<detailed_description>Studies last year clearly establish least 25 % men type 2 diabetes subnormal free testosterone ( T ) concentration association inappropriately low leutinizing homromone ( LH ) FSH ( follicle stimulate hormone ) concentration . These patient thus suffer hypogonadotrophic hypogonadism ( HH ) . Obesity metabolic syndrome also associate HH . Animal study vitro data show insulin action insulin responsiveness brain necessary maintenance functional integrity hypothalamo-hypophyseal-gonadal axis . Insulin concentration increase brain delivering insulin intranasally vianase device . The aim project study effect one dose intranasal insulin release LH obese diabetic men HH . 15 obese men type 2 diabetes low free T along normal LH concentration recruit study . The study carry clinical center Texas Tech ( Odessa campus ) . There two study visit , comprise blood test every 15 minute 6 hour . 40 IU intranasal insulin saline give baseline period blood sample 2 hour . Student 's t-test use compare change LH concentration intranasal saline insulin .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Males age 18 75 year Obesity ( BMI ≥30 kg/m2 ) Type 2 diabetes Hypogonadotropic hypogonadism define calculated free testosterone concentration 7 ng/dl along normal low LH concentration HbA1c &gt; 8.5 % Use preprandial insulin therapy Use testosterone currently past 4 month Use counter health supplement contain androgen Use corticosteroid narcotic past 3 month Coronary event procedure ( myocardial infarction , unstable angina , coronary artery bypass , surgery coronary angioplasty ) previous twelve week Type I Diabetes Currently suffer foot ulcer , significant periodontal disease chronic infectious inflammatory condition Hepatic disease ( transaminase &gt; 3 time normal ) cirrhosis Renal impairment ( define GFR &lt; 30 ) HIV Hepatitis C positive status Any lifethreatening , noncardiac disease History untreated severe obstructive sleep apnea ( define apneahypopnea index ≥30 ) currently suffer symptomatic depression , without treatment Use investigational agent therapeutic regimen within 30 day study Participation concurrent clinical trial Pituitary tumor/damage/ trophic hormone deficiency</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>hypogonadotropic hypogonadism</keyword>
</DOC>